BLOG
Life Sciences


Glaswegian Hospitality Sets the Tone for A Successful ISPOR Glasgow Conference

Written by Dana Weiss in Life Sciences on 14/11/17


AMPLEXOR Life Sciences exhibited at the 20th Annual European Congress of ISPOR - The International Society for Pharmacoeconomic Research - in Glasgow, Scotland last week. The conference drew more than 4700 attendees from the health economics and outcomes research (HEOR) community with this year’s theme being “The Evolution of Value in Health Care”. Topics discussed included the evolution of Health Technology Assessments (HTAs), the use of Real-World Evidence (RWE) to Support Regulatory Approvals, and Reimbursement Systems Across Europe.
Read more

Labelling and Data Management: it’s all about the bigger picture

Written by Romuald Braun in Life Sciences on 20/09/17


For some firms in life sciences, product labelling is treated as a distinct, manually-driven process. This is a legacy of an era when technology was trusted and reliable than it is now, and it’s also a major error, as it can leave an organisation vulnerable to risk, such as costly product recalls, and inefficiency.

Read more

How Artificial Intelligence is impacting life sciences

Written by Elvis Paćelat in Life Sciences on 20/09/17


Artificial Intelligence (AI) is one of the most talked-about technologies of the last decade. It saw more deployment initially in other industries – telecoms and financial services (FS) were amongst the early adopters - but the past few years have seen a number of life sciences firms embrace AI and reap some of the benefits.

Read more

IDMP: A Big Data Challenge for European Pharma

Written by Andrew Marr in Life Sciences on 23/05/17


At this year’s AMPLEXOR “Be The Expert 2017” event, Pharm Exec spoke to Andrew Marr about the implications of the EU’s new IDMP (Identification of Medicinal Products) regulations for the pharmaceutical industry.

Read more

Life sciences set for the next stage of a technological revolution

Written by Sonja Vlašič in Life Sciences on 23/05/17


AMPLEXOR recently staged its 19TH annual life sciences conference, BE THE EXPERT 2017. Across three days of debate, discussion and presentations in Budapest, delegates learned more about some of the issues facing the life sciences industry in 2017 and also about some of the technological solutions that are available to address these issues. Elvis Paćelat, Vice President, Life Sciences, AMPLEXOR, gives an overview of what was discussed and where he feels the industry is heading.

Read more

Disrupt or be disrupted: Why the pressure is mounting for life sciences to take digital transformation seriously

Written by Elvis Paćelat in Life Sciences on 31/03/17


All life sciences organizations are under pressure to change. If the preventative healthcare and wellness trend doesn’t turn the industry upside down, it will be something else – from the need for more holistic remedies to the expectation of greater transparency.

Read more

Pursuing World Class RIM Part 4: Authoritative Source and Data Standards Update

Written by Steve Gens in Life Sciences on 03/01/17


Designation of specific RIM systems and repositories as the authoritative source for regulatory information has been the standard for many years as evidenced by our previous RIM research. In 2016 we took the next step towards understanding regulatory information authoritative sources by asking each company to assess their confidence in the data within the authoritative source for 10 essential capabilities.

Read more

Pursuing World Class RIM Part 3: Applying Emerging Technologies in the RIM Space

Written by Steve Gens in Life Sciences on 23/11/16


We have been discussing and anticipating the promise of emerging technology to significantly improve Regulatory Information Management (RIM) systems for the last few years. Historically traditional methods, such as more powerful servers and faster internal networks, shared workspaces and incremental software upgrades have provided relatively little business improvement.
Read more

Pursuing World Class RIM Part 2: Comparing RIM Operating Models

Written by Steve Gens in Life Sciences on 17/11/16


For years, RIM software vendors have talked about the importance of having a common platform or suite of products for successful management of regulatory information. For industry, a “common” capability requires much more than a set of tools. It requires common processes across sites and geographies, standardized data definitions and entry criteria for the information captured within the RIM systems, as well as enforcement of those standards.

Read more

Pursuing World Class RIM Part 1: What is World Class RIM?

Written by Steve Gens in Life Sciences on 08/11/16


Me and my colleagues (Greg Brolund from Chicopee Falls Consulting and Sarah Powell from Powell Regulatory Services) write an annual white paper to provide a clear industry status of Regulatory Information Management (RIM) highlighting the current state, key trends and priorities, investment focus, projected capability and organization change, and a comprehensive update on the provider landscape. This year we have an exciting addition that focuses on defining and measuring World Class RIM.

Read more